Alzheimer disease pathology as a host response

Area of Science:

• Neuroscience
• Pathology
• Biochemistry

Background:

• Alzheimer disease (AD) research historically focused on amyloid-beta and tau pathology.
• The amyloid cascade hypothesis posits these lesions drive AD pathogenesis.
• Recent findings question the direct toxicity and clinical relevance of these end-stage lesions.

Purpose of the Study:

• To re-evaluate the role of amyloid-beta and tau lesions in Alzheimer disease.
• To explore alternative interpretations of AD pathogenesis, focusing on upstream factors.
• To guide therapeutic strategies by questioning the direct targeting of hallmark lesions.

Main Methods:

• Literature review and critical analysis of existing Alzheimer disease research.
• Conceptual re-framing of AD pathology as a host response.
• Emphasis on investigating upstream pathophysiological processes.

Main Results:

• The study suggests senile plaques and neurofibrillary tangles may be non-toxic host responses.
• The relationship between AD lesions and clinical symptoms is inconsistent.
• Toxic intermediates like amyloid-beta oligomers are considered but their role is debated.

Conclusions:

• Alzheimer disease hallmark lesions might be a consequence, not the cause, of the disease.
• Therapeutic success may depend on targeting the upstream cause rather than the end-stage lesions.
• Further research into fundamental age-related processes like oxidative stress and inflammation is warranted for AD.